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Influenza A virus is an RNA virus that encodes up to eleven proteins and this small coding 
capacity demands that the virus utilize the host cellular machinery for many aspects of its 
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life cycle1. Knowledge of these host cell requirements not only informs us of the molecular 
pathways exploited by the virus but also provides additional targets that could be pursued 
for antiviral drug development. Here, we employ an integrative systems approach, based 
upon genome-wide RNAi screening, to identify 295 cellular cofactors required for early-
stage influenza virus replication. Within this group those involved in kinase-regulated 
signaling, ubiquitination and phosphatase activity are the most highly enriched and 181 
factors assemble into a highly significant host-pathogen interaction network. Moreover, 219 
of the 295 factors were confirmed to be required for efficient wild-type influenza virus 
growth and further analysis of a subset of genes revealed 23 factors necessary for viral entry, 
including members of the vacuolar ATPase (vATPase) and COPI-protein families, fibroblast 
growth factor receptor (FGFR) proteins, and glycogen synthase kinase 3 (GSK3)-beta. 
Additionally, 10 proteins were confirmed to be involved in post-entry steps of influenza 
virus replication. These include nuclear import components, proteases, and the calcium/
calmodulin-dependent protein kinase (CaM kinase) II beta (CAMK2B). Importantly, growth 
of swine-origin H1N1 influenza virus is also dependent on the identified host factors and we 
show that small molecule inhibitors of several factors, including vATPase and CAMK2B, 
antagonize influenza virus replication.
Influenza viruses are a major cause of morbidity and mortality, and influenza A viruses in 
particular have the propensity to cause pandemic outbreaks such as occurred in 1918, 1957, 
1968 and currently in 2009 with the swine-origin H1N1 influenza virus2. Two of the viral 
proteins, neuraminidase (NA) and the M2 ion channel protein are the targets for the FDA-
approved influenza antiviral drugs; oseltamivir, zanamivir, amantadine and rimantadine 3. 
Unfortunately, there is now widespread resistance to both of these drug classes 4. Combined 
with the limited number of viral drug targets for influenza virus, this creates concern for the 
development of new influenza therapies.
An alternative therapeutic strategy that may greatly reduce the emergence of viral resistance 
is the pharmacological targeting of host factors required for viral replication. Genome-wide 
RNAi screens have enabled the identification of host factors required by a number of RNA 
viruses 5–7 8 9, 10 11, including an insect cell-based RNAi screen which implicated 110 
Drosophila genes in influenza virus replication 12. In an effort to more comprehensively 
characterize the host machinery utilized by influenza virus in mammalian cells, we have 
performed a genome-wide siRNA screen with human lung epithelial (A549) cells. To 
facilitate the readout for the high-throughput screen, the coding region for the influenza 
A/WSN/33 virus hemagglutinin (HA) protein was replaced with that of Renilla luciferase 
(Figure 1a)13. As no HA is produced, this recombinant virus cannot complete its replication 
cycle. Thus our RNAi screen focuses on the cellular requirements for viral entry, uncoating, 
nuclear import, and viral RNA transcription/translation, but is not expected to identify 
factors involved in virus assembly, budding or release.
An arrayed siRNA library targeting over 19,000 human genes was employed to transfect 
human A549 cells (Figure 1b and Supplementary Information). These cells were infected 
with the modified influenza virus (WSN-Ren), and luciferase readings were taken after 12, 
24, and 36h. Data from two independent screens were analyzed using an integrative data 
analysis approach, which included Redundant siRNA Activity (RSA), as well as interactome 
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and ontology-based analyses, (see Supplementary Information)6, 14. Using these 
methodologies, we were able to confirm 295 cellular genes for which at least 2 siRNAs 
reduced viral infection by 35% or greater (~2 standard deviations from mean of negative 
controls), without a concomitant induction of significant cellular toxicity (Supplementary 
Figure S1 and Supplementary Table S1). While some of these factors were previously 
known to be involved in influenza virus replication (confirming the robustness of our RNAi 
approach), the majority of the factors identified through this analysis represent host genes 
that have not previously been implicated in mediating influenza virus replication.
Analysis of over-represented biological annotations identified over 170 statistically enriched 
categories (Supplementary Table S2), which fell into 11 broadly related functional groups 
(Supplementary Figure S2, Supplementary Table S3). Signaling molecules, including those 
involved in the PI3K/AKT pathway, molecules that function to regulate cytoskeletal 
dynamics, and proteins involved in ubiquitination, phosphatase, and protease activities were 
overrepresented amongst the 295 factors, underscoring the importance of these cellular 
functions during influenza virus infection (Table 1, see also Supplementary Table S4 and 
S5). Consistent with these observations, we found that small molecule inhibition of two 
identified AKT pathway regulators, mTOR (FRAP1) and HSP90AA1, as well as 
microtubule assembly (TUBB), resulted in a dose-dependent inhibition of influenza virus 
replication (Supplementary Figure S3)15, 16.
To understand the network of host-pathogen interactions that govern the early steps of 
influenza virus replication, we employed several protein interaction datasets to construct a 
host-pathogen interaction map depicting associations between the identified host factors, 
viral-encoded proteins, and other cellular proteins (Figure 1c, Supplementary Figures S4 and 
S5). The integration of RNAi and interactome datasets produced a network containing 181 
confirmed host cellular factors that mediate 4,266 interactions between viral or cellular 
proteins, and act as central rate-limiting “hubs” in cellular pathways or processes required 
for influenza virus replication (Supplementary Figure S6, Supplementary Table S6). 
Although the coverage and quality of currently available protein interaction databases 
remains difficult to assess17, the influenza interaction map was found to be highly 
significant (p<0.001), indicating that this network topology is not randomly derived, and 
likely reflects a unique cellular sub-network.
Of the 295 identified host factors required for influenza virus replication, 53 were previously 
identified in RNAi screens for different RNA viruses (Supplementary Figure S7, 
Supplementary Table S7), including 9 mammalian orthologues of host proteins required for 
influenza virus infection of Drosophila cells 12. It is currently not clear if this statistically 
significant (p=3.1 × 10−9), but modest, overlap reflects false-negative activities in the 
current or the aforementioned screen, or the differential host cell requirements between 
insect and mammalian cells for influenza virus replication. However, functional 
classification and protein interaction analysis of these shared factors revealed that, 
collectively, these viruses rely on common host cellular mechanisms to promote discrete 
stages of their life cycles (Figure 1d, Supplementary Figure S8; Supplementary Table S8).
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To verify that the genes identified through the use of the reporter virus reflect the 
requirements in the context of a wild-type (WT) virus infection, 219 of 295 identified genes 
were confirmed to inhibit multi-cycle replication of WT WSN virus with at least two 
siRNAs per gene. Furthermore, 76% of the remaining genes had one siRNA that inhibited 
WT influenza replication, indicating a high confirmation rate (Figure 2a, Supplementary 
Table S9). For a subset of these genes additional assays were undertaken to confirm that 
depletion of these genes resulted in reduced viral gene expression (Figure 2a, Supplementary 
Table S9), and also to ensure that inhibition of viral replication was not being triggered by a 
non-specific siRNA-mediated induction of an antiviral state (Supplementary Table S10).
Next, to identify potential factors specifically involved in virus entry steps, 45 of the top-
scoring genes in the WT WSN assay were selected to be tested in a pseudotyped particle 
(PP) entry assay, designed to identify host factors that impede low-pH-dependent entry 
mediated specifically by influenza virus HA (WSN) and vesicular stomatitis virus (VSV)-G 
protein, while not affecting pH-independent entry promoted by the murine leukemia virus 
(MMLV) envelope (Env) 18, 19. WSN-PP infection was reduced in the presence of siRNAs 
targeting 23 of these genes, including CD81, FGFR4, GSK3B, MAP2K3 and the v-ATPase 
subunit ATP6V0C (Figure 2a, 2b, Supplementary Table S11, Supplementary Figure S9). 
These genes were also required for efficient VSV-G-PP (but not MMLV-PP) infection, 
suggesting a role in low-pH-dependent virus entry. Importantly, small molecule inhibitors of 
FGFR4, GSK3B, and v-ATPase activities attenuated replication of WSN virus, further 
highlighting their importance in influenza virus infection (Supplementary Figures S3 and 
S10).
The COPI coat complex is made up of seven subunits, four of which (ARCN1, COPA, 
COPB2, COPG) were among the confirmed factors in the protein interaction network 
(Figures 1c and 2c). COPI association with endosomes is pH-dependent and coatomer 
complex is required for the formation of intermediate transport vesicles between the early 
and late endosomes 20, 21. Consistent with this role, depletion of COPG and ARCN1 both 
blocked WSN-PP infection (Figure 2b). The requirement for ARCN1 during the influenza 
virus entry step was further demonstrated using a more direct virus-like particle (VLP) assay 
(Figure 2d)22, as well as immunolocalization studies (Figure 2e).
To evaluate those factors that affect virus replication but not influenza virus entry, we 
monitored the localization of the influenza virus nucleoprotein (NP) in siRNA-depleted cells 
after infection with influenza A/WSN/33 virus (Figure 3a; Supplementary Figure S11, see 
Supplementary Information). In comparison to controls, cells depleted of CSE1L, PRSS35, 
F13A1, SF3A1, CAMK2B, KPNB1, and PPP1R14D show a significant decrease (p<0.01) 
of nuclear to cytoplasmic ratios of NP protein at 180 min. With the exception of F13A1, 
depleting these factors did not inhibit entry by WSN pseudotyped virus or β-lactamase 
(Bla)-M1 VLPs (Figure 3a), confirming their role in post-entry steps of influenza virus 
infection. Depletion of CSE1L, PRSS35, and F13A1 also led to a statistically significant 
(p<0.02) reduction of nuclear to cytoplasmic NP ratios at 90 minutes post-infection, 
suggesting that they may play specific roles in early post-entry steps, such as viral uncoating 
or nuclear import of viral ribonucleoproteins (vRNPs; see also Supplementary Figure S12). 
Consistent with a role in nuclear trafficking, imaging at higher resolution confirmed that 
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RNAi-mediated inhibition of CSE1L, but not CAMK2B or KPNB1, results in a decrease in 
nuclear vRNPs typically seen 90 min after infection with influenza virus (Figure 3b)23. 
Furthermore, CSE1L specifically inhibited influenza virus gene expression in a mini-
genome replicon assay, suggesting that CSE1L activity is required for the nuclear import of 
vRNPs as well as newly synthesized viral proteins (Figure 3c, Supplementary Table S12).
Calcium/calmodulin-dependent protein kinase (CaM kinase) II beta (CAMK2B) is a 
ubiquitously expressed calcium sensor that regulates diverse cellular functions, including 
actin cytoskeletal regulation and CREB-dependent transcription 24. Our data implicate this 
kinase in the regulation of viral RNA transcription as RNAi-knockdown of the kinase had a 
moderate effect on expression of an influenza mini-genome (Figure 3c), but did not delay 
nuclear accumulation of vRNPs at 90 min post-infection (Figure 3b). We also show that a 
specific inhibitor of CAMK2B, KN-93, inhibits influenza virus growth (Figure 3d, 
Supplementary Figure S13), suggesting that pharmacological targeting of this kinase may be 
an effective strategy for the development of host factor-directed antivirals25.
Finally, we assessed the requirements for twelve identified host cellular factors in the 
replication of a swine-origin influenza virus (SOIV) isolate from the 2009 pandemic (A/
Netherlands/602/2009 (H1N1)) in comparison with influenza A/WSN/33 virus and VSV. 
Viral growth in siRNA-treated A549 cells revealed that these proteins are all required for 
both SOIV and WSN replication but none of these factors, with the exception of the 
vATPase and COPI factors, inhibited VSV replication (Figure 3e, Supplementary Table 
S13, Supplementary Figure S14). These results indicate that factors identified here are likely 
important for the replication of multiple influenza virus strains.
This genome-wide analysis of influenza virus host factor requirements described here has 
revealed a large number of cellular proteins and biological pathways previously unknown to 
be involved in the influenza virus life-cycle. These include the identification of COPI 
complex, FGFR, GSK3B, CAMK2B, PRSS35, and others. Since this study focused on host 
factors that regulate the early steps of influenza virus replication, additional analyses will 
likely help to elucidate the full complement of cellular proteins required during the complete 
replication cycle. Further understanding of the roles for these proteins in influenza virus 
infection will provide new insight into the host-pathogen interactions that orchestrate the 
viral replication cycle and novel opportunities for the development of host factor-directed 
antiviral therapies.
Methods
Renilla luciferase influenza virus
The coding region for the viral hemagglutinin (HA) protein was replaced with that of 
Renilla luciferase and the packaging signals for the HA segment were incorporated, as 
previously described 13. The recombinant WSN-Ren virus was generated by reverse 
genetics in the presence of complementing HA and amplified in HA-expressing MDCK 
cells 13.
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Genome-wide RNAi screen
Genome-wide libraries comprising 98,737 synthetic siRNAs targeting 19,628 unique human 
genes were arrayed in 384-well plates (7ng/siRNA) such that each well contained either two 
(47,560 wells) or one (3617 wells) unique and identifiable siRNA per gene. Although use of 
low screening concentrations of RNAi may help to minimize off-target activities, this may 
also contribute to false-negative activities. The library matrix was introduced into A549 cells 
through a high throughput transfection process 26, 27 and after 48h the cells were infected 
with WSN-Ren virus at a multiplicity of infection (MOI) of 0.5. EnduRen Live Cell 
substrate (Promega) was added after 5 hours and relative luminescence for each well was 
analyzed on a plate reader (Viewlux) at 12h, 24h and 36h after infection. For the toxicity 
screen Cell-titer-glo (Promega) reagent was added 72h after siRNA transfection. The 
screens were run minimally in duplicate and analyzed using a scaling methodology that sets 
the positive control siRNA at an arbitrary value of 0.1, and the negative control siRNAs at 1. 
siRNAs targeting host factors were assigned a score based on the distribution of these 
values. For more details see Supplementary Information.
Inhibition of virus growth
siRNA-transfected A549 cells were infected with either influenza A/WSN/33 virus or VSV 
(MOI of 0.01) or swine origin influenza A/Netherlands/602/2009 virus (SOIV) (MOI of 1) 
at 48h post siRNA transfection. At 36h post infection supernatants were harvested and virus 
titers were determined by plaque assay on MDCK cells (for A/WSN/33 and A/Netherlands/
602/2009) or on Vero cells for VSV.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. A Genome-wide RNAi Screen for Influenza Virus Host Cellular Factors
(a) A schematic of the recombinant WSN-Ren virus showing the HA segment modified to 
express Renilla luciferase but maintaining the HA packaging sequences. (b) An arrayed 
genome-wide RNAi library (100,000 siRNAs targeting over 19,000 human genes) was 
transfected into A549 cells. Cells were subsequently infected with WSN-Ren and virus 
replication was monitored by measuring luciferase activities at the indicated times. (c) A 
highly significant (p<0.001 based on permutation test) host-pathogen interaction map for 
influenza virus containing 4,266 interactions between 181 confirmed influenza virus-host 
cellular factors (green circles), 10 influenza virus-encoded proteins or complexes (red 
circles), and an additional 184 cellular proteins (orange circles). (d) Predicted complexes 
from the human interactome used by influenza virus, HIV, HCV, dengue virus, and West 
Nile virus (based upon results reported here and previous screens5–8, 10–12, 28). Intensity 
of red colour indicates the significance of enrichment (based on hypergeometric p-values) 
for proteins required by a virus within a complex.
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Figure 2. Identification of Host Factors Involved in Influenza Virus Entry
(a) Illustration of the screen progression from primary genome-wide analysis to the 
identification of factors involved in entry and post-entry steps in the virus life cycle. The 
number of confirmed genes and number of genes tested at each stage (in parentheses) are 
indicated. (b) The relative effects of gene depletion (2 siRNAs/gene) on infection of 
luciferase-encoding HIV particles pseudotyped with WSN, VSV or MMLV envelopes (right 
panel). Effects of RNAi upon wild-type WSN virus replication and transcription of viral NP 
and M1 genes are also shown (left panel). Inhibition in each assay is shown as a continuum 
König et al. Page 10
Nature. Author manuscript; available in PMC 2010 August 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
of blue (high inhibition) to yellow (low inhibition). (c) The endosomal coat protein complex 
(COPI) was identified as one of seventeen biochemical modules (MCODE clusters) likely to 
be important for influenza virus entry (see Figure 1c for legend; also Supplementary Figure 
S5)29. (d) Infection of siRNA-transfected A549 cells with influenza virus VLPs carrying a 
beta-lactamase (Bla-M1) fusion protein. The percentages of cells containing detectable 
cytoplasmic beta-lactamase activity are indicated. (e) Cells depleted of ARCN1 and infected 
with wild-type WSN virus were fixed and stained for NP (green) and nuclei (blue) at the 
indicated times and analyzed by confocal microscopy. The enlarged images at 90min post-
infection indicate the lack of incoming RNP complexes in the nucleus in cells depleted of 
ARCN1.
König et al. Page 11
Nature. Author manuscript; available in PMC 2010 August 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Characterization of Factors in Post-Entry Replication Events and Conserved 
Requirement by Different Influenza Viruses
(a) The impact of host factor depletion on the nuclear localization of viral NP protein at 90 
and 180 minutes after A/WSN/33 virus infection is shown (right panel). Significant effects 
(p<0.01 based on Welch T-test) are seen at 180min with all genes and with CSE1L, 
PRSS35, F13A1 (p<0.02) at 90min. Levels of virus replication (WT WSN), viral gene 
(NP/M1) transcription and entry of WSN pseudotyped particles or Bla-M1 VLPs in cells 
lacking these factors are shown in the left panel. Values relative to negative controls (bottom 
row) are depicted in a continuum of blue (>95% inhibition) to yellow (little or no 
inhibition). (b) Confocal imaging of influenza virus NP protein localization at the indicated 
times following A/WSN/33 virus infection in cells depleted of CSE1L, CAMK2B and 
KPNB1. Arrows in the 90’ inset indicate nuclear RNPs. (c) The effects of host factor 
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depletion on replication of an influenza virus mini-genome firefly reporter. The normalized 
fold reduction of firefly luciferase for each gene is shown relative to the scrambled siRNA 
control (SC1) +/− standard deviation. All reductions are significant (p<0.05) by Student’s T-
test. (FF=firefly luciferase siRNA). (d) KN-93, a selective inhibitor of CAMK2B, inhibits 
A/WSN/33 influenza viral replication in a dose-dependent manner in MDCK cells, without 
affecting cell viability (ATP levels). Mean titers +/− standard deviation of triplicate samples 
are shown. (e) A549 cells were transfected with siRNAs targeting the indicated genes and 
subsequently infected with influenza A/WSN/33 virus, swine-origin influenza A/
Netherlands/602/2009 (H1N1) virus (SOIV) or VSV. Virus growth is shown as the average 
percent relative to the scrambled siRNA control (SC1) +/− standard deviation. *below level 
of detection (1 × 104 pfu/ml). NP=siRNA for influenza A virus NP, RPS=siRNA for 
RPS27A.
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Table 1
Selected functional categories in early steps of influenza virus replication
Functional
Category Gene Names a Cellular function
Proposed/known role in influenza 
virus
replication b
Replication
block
IP3-PKC pathway
ROCK1, CDC42BPA, KSR2, 
ARAF,
PRKCI, CDC42BPB, CIT, 
AKAP13,
RACGAP1, EIF2AK2, CDK4, 
ACVR2A,
MAPK1, PRKCD, MAP2K2, 
GRK5,
ARAF, HIPK1, PAK3, MAP2K3,
PTPMT1, LIMK1, PIP5K1C, 
PAK2,
GRK6, SGK1
Signaling
Viral entry, promoting apoptosis; 
inhibitors of
PKC block viral RNA replication and 
PKC
activators enhance virus replication
Entry
(MAP2K3)
COPI vesicles ARCN1, COPA, COPB2, COPG, USE1
early endosome
maturation,
retrograde golgi to
ER transport
entry (endosomal trafficking) Entry(ARCN1)
Endosomal
uptake,
maturation,
acidification and
fusion
ATP6V1A, ATP6V1B2, 
ATP6V0B,
ATP6V0C, ATP6AP1, 
ATP6V0D1,
ATP6AP2, RABEP1, PIP5K1C, 
VPS16,
TRPV2, MARCH2, EPHB2
vATPase complex:
acidification of
intracellular
organelles, including
endosomes
Low pH-dependent entry, ubiquitin/
vacuolar
protein sorting pathway required for 
entry
Entry
(ATP6V1A,
ATP6V1B2,
ATP6V0B,
ATP6V0C,
ATP6AP1)
Actin
organization and
function
GAK, APC2, CIT, PAK2, 
CDC42BPB,
PAK3, CDC42BPA, SGCA, 
FSCN1,
OXSR1, CD81, FGFR2, FGFR4, 
ITGA3,
AKAP13, ACTC1, FGFR1, 
LIMK1, ROCK1,
PIK3R4
Actin organization
and function
Intracellular transport, Particle 
movement at
cell periphery prior to virus fusion; 
Actin also
implicated in NP functions such as
transcription, replication, and genome-
trafficking
Entry (CD81,
FGFR2
FGFR4,
ITGA3,
AKAP13)
PI3K–AKT
pathway
AKT1, BCL3, FRAP1, GSK3B, 
HRAS,
HSP90AA1, IKBKE, ITGA3, 
JAK2,
MAP2K2, MAPK1, MDM2, 
PIK3R4,
PIK3R4
Signaling
important for viral protein yields and 
nuclear
export of vRNPs. Involved in inhibition 
of
apoptosis.
Entry
(GSK3B)
Endosomal
recycling
pathway
RAB11B, RAB17 Vesicle trafficking entry (endosomal trafficking) Entry(RAB11B)
MAPK pathway
MAP2K3, DUSP3, MAP3K12,
MAPK1/ERK, MAP2K2/MEK, 
ARAF, CAD,
CREB1, EPHB2, FGFR4, HRAS, 
JUN,
NTRK2, PAK2, PRKACA, 
PRKCD,
MAP2K5, MAP4K4, HIPK3, 
ATP6AP2,
STK39, MINK1, PBK, TAOK1, 
ZNF436,
CANT1, KSR2
Signaling
important for viral protein yields and 
nuclear
export of vRNPs.
Entry
(MAP2K3,
DUSP3)
Proteases CTSW, PCSK7, KLK9, ANPEP, PRSS35
Post-translational
processing HA cleavage
Post-entry
(PRSS35)
Calcium/
Calmodulin
Proteins
CAMK2B, PRKACA, DAPK2, 
ADRA1B,
Calcium regulation
and signaling Transcriptional regulation
Post-entry
(CAMK2B)
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Functional
Category Gene Names a Cellular function
Proposed/known role in influenza 
virus
replication b
Replication
block
CREB1, PRKAG2, DCLK2, 
GRK5, GRK6,
KCNJ3, PKD1, PRKCD, STX5, 
CACGN4,
AGTRAP
Nuclear
trafficking
CSE1L, KPNB1, NUP214, 
NUP153,
TNPO3
Nuclear trafficking Nuclear import of vRNA or viral/host proteins
Post-entry
(KPNB1,
CSE1L)
Trafficking STX10, STX5, GOPC, CLL1, NRBP1
Membrane and
Receptor trafficking Glycoprotein trafficking ND
Sumoylation SUMO2, SUMO1, SAE1, SUMO4
Post-translational
modification unknown ND
Microtubule
organization and
function
MID1IP1, TUBB, PRKCI, PLK4, 
MARK2,
DCLK1, NUDCD3, RACGAP1, 
MAP1LC3C
Cytoskeletal
organization
Microtubules implicated in intracellular 
viral
transport.
ND
Autophagy PRKAG2, MAP1LC3C, FRAP1, HRAS Stress response
post-entry, blocks viral protein 
production ND
Ubiquitination
MDM2, UBQLN4, HECTD1, 
CBLL1, DTX2,
EPS8L3, FBXO44
Post-translational
modification unknown ND
a, b
References are contained in Supplemental Table 5. ND = No Data
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